ReviewAnnals of vascular diseases2017
Coronary Artery Bypass Surgery in End-Stage Renal Disease Patients.
Review in Annals of vascular diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 21 citations in OpenAlex.
- Post-operative and long-term outcomes in dialysis and non-dialysis patients undergoing on-pump and off-pump CABG: a nationwide cohort analysis.Journal of cardiothoracic surgery · 2025Article
- Dulaglutide markedly prevents peritoneal fibrosis in a rodent model of chronic kidney disease: Insights into the pathogenesis.International journal of molecular medicine · 2025Article
- Challenging the Paradigm: Long-Term Outcomes in Dialysis-Dependent Patients Undergoing CABG.Journal of cardiovascular development and disease · 2025Article
- Reconstruction Technique Options for Achieving Total Arterial Revascularization and Multiple Arterial Grafting.Journal of clinical medicine · 2023Review
- Impact of Chronic Kidney Disease on Clinical Outcomes during Hospitalization and Five-Year Follow-Up after Coronary Artery Bypass Grafting.Critical care research and practice · 2023Article
- The outcomes of ultrafiltration in on-pump versus off-pump coronary artery bypass grafting in patients with renal impairment.Journal of cardiothoracic surgery · 2022Article
- Coronary artery bypass grafting vs. percutaneous coronary intervention in coronary artery disease patients with advanced chronic kidney disease: A Chinese single-center study.Frontiers in surgery · 2022Article
- Rapid decline in cardiac function in diabetic patients with calcified coronary artery disease undergoing hemodialysis: two case reports.BMC cardiovascular disorders · 2021Article
- Long-term prognosis in patients with end-stage renal disease after coronary artery bypass grafting.Journal of thoracic disease · 2020Article
- Outcomes and Patency of Complex Configurations of Composite Grafts Using Bilateral Internal Thoracic Arteries.The Korean journal of thoracic and cardiovascular surgery · 2020Article
- Prosthesis selection for aortic valve replacement in patients on hemodialysis.General thoracic and cardiovascular surgery · 2020Article
- Predictors and Outcomes of Cardiac Events following Thoracic Endovascular Aortic Repair in Descending Thoracic Aortic Aneurysm and Dissection.Aorta (Stamford, Conn.) · 2020Article
- Comparison between three different equations for the estimation of glomerular filtration rate in predicting mortality after coronary artery bypass.BMC nephrology · 2019Article
- Surgical outcomes of acute type A aortic dissection in dialysis patients.General thoracic and cardiovascular surgery · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The number of patients requiring hemodialysis is continuously increasing around the world. Hemodialysis affects patient quality of life and it is also associated with a higher risk for cardiovascular events. In addition to traditional risk factors for cardiovascular events such as hypertension, hyperlipidemia, and diabetes, hemodialysis is associated with hyperphosphatemia, chronic inflammation, vascular calcification, and anemia which accelerate atherosclerosis, vascular stiffness, and cardiac ischemia. Treatment strategy for coronary revascularization in this progressive disease remains controversial. However, a systematic treatment including medical therapy and complete revascularization through a less invasive strategy should be considered in addressing this problem. This review discusses the epidemiology, vascular pathology and current treatment options in patients with end-stage renal disease requiring coronary revascularization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.